Ubs Group Ag Stereotaxis, Inc. Transaction History
Ubs Group Ag
- $527 Billion
- Q4 2024
A detailed history of Ubs Group Ag transactions in Stereotaxis, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 41,147 shares of STXS stock, worth $76,121. This represents 0.0% of its overall portfolio holdings.
Number of Shares
41,147
Previous 12,643
225.45%
Holding current value
$76,121
Previous $25,000
272.0%
% of portfolio
0.0%
Previous 0.0%
Shares
21 transactions
Others Institutions Holding STXS
# of Institutions
92Shares Held
41.8MCall Options Held
217KPut Options Held
4.1K-
Dafna Capital Management LLC Los Angeles, CA13.7MShares$25.3 Million8.48% of portfolio
-
Lagoda Investment Management, L.P. New York, NY4.13MShares$7.63 Million5.1% of portfolio
-
Black Rock Inc. New York, NY3.54MShares$6.55 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.48MShares$6.43 Million0.0% of portfolio
-
Arbiter Partners Capital Management LLC New York, NY2.79MShares$5.16 Million4.96% of portfolio
About Stereotaxis, Inc.
- Ticker STXS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 74,790,096
- Market Cap $138M
- Description
- Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by pr...